WoS ESCI Q2Scopus Q2SCImago #6,196CAS 3区Gold OA

Pharmacoeconomics-Open

Country: United Kingdom•WoS SCIE Quartile: Q2•Scopus SJR: 0.86•SCImago Rank: #6,196•Identifier (ISSN):2509-4262(Print)/2509-4254(Online)•Articles / Year: 68•Estimated Publication Fee (APC): $3,114 USD

Clarivate JCR Index Advisory: Active (ESCI)

Clarivate IF (2026)Q2

2.4

↑ +0.3

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17

H-Index (Hirsch Index)

28 papers with at least that number of citations each

WoS: ESCIQ2

Self-Citation Rate5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

68articles/year

100% Gold OA•90% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.75pts

Latest Max Score

Estimated (Dec 26)

Scoring Basis: WoS Q2 có IF ≥ 2.0(IF: 2.4)

HĐGSNN Score History

By article publication year

Year	Max Score	Evaluation Details	Source
2026	1.75đ	WoS Q2 có IF ≥ 2.0(IF: 2.4)	🔵 Computed
2025	1.75đ	WoS Q2 có IF ≥ 2.0(IF: 2.1)	🔵 Computed
2024	1.75đ	WoS Q2 có IF ≥ 2.0(IF: 2)	🔵 Computed
2023	1.75đ	WoS Q2 có IF ≥ 2.0(IF: 2)	🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

PharmacoEconomics - Open focuses on applied research on the economic implications and health outcomes associated with drugs, devices and other healthcare interventions. The journal includes, but is not limited to, the following research areas:Economic analysis of healthcare interventionsHealth outcomes researchCost-of-illness studiesQuality-of-life studiesAdditional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in PharmacoEconomics -Open may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.

Topics Covered (Recognized by AI)

Medicine93.6%Biology72.7%Internal medicine69%Economics61%Pathology59.2%Mathematics52%Political science48.3%Law47.5%Statistics47.5%Business46.2%Psychology45.1%Surgery35%Nursing31.6%Engineering30.8%Economic growth29.7%Genetics28.9%Psychiatry28.1%Health care28.1%Sociology27.9%Management27.9%Computer science27.6%Operations management24.7%Environmental health22.8%Demography22.8%Risk analysis (engineering)22.5%Chemistry21%Cost effectiveness21%Immunology20.7%

Primary Research Areas

Multiple

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,196Scopus Q2SCImago Profile

Scopus Coverage:2017-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q2

0.86

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2

Scopus H-Index (2025)

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)

Citations / Doc (2 years)

2.83

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,114 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations574

3-Year Documents218

Citable Documents213

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate41.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Health PolicyQ2

PharmacologyQ2

Pharmacology (medical)Q2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ECONOMICS

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed

Updating

Average time to first editorial decision

Online Publication Speed

Updating

Time from acceptance to online publication

Official Acceptance Rate

Updating

Manuscript acceptance rate confirmed by the publisher

Open Access Model

Gold OA

OA publishing option or traditional subscription

Publisher

Adis, Springer Healthcare

Publication Language

English

Frequency

6 issues per year

Indexing & Databases

ESCIScopusDOAJPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

Category	Index	Rank	Quartile
ECONOMICS	JCRESCI	196/626	Q2
HEALTH CARE SCIENCES & SERVICES	JCRESCI	97/194	Q2
HEALTH POLICY & SERVICES	JCRESCI	56/125	Q2
PHARMACOLOGY & PHARMACY	JCRESCI	215/356	Q3
ECONOMICS	JCIESCI	211/627	Q2
HEALTH CARE SCIENCES & SERVICES	JCIESCI	93/194	Q2
HEALTH POLICY & SERVICES	JCIESCI	68/125	Q3
PHARMACOLOGY & PHARMACY	JCIESCI	149/356	Q2